Organon & Co. Common Stock

Afficher le graphique complet Full chart

Financials

Total de l'actif 13.1 B13.16 B13.5 B13.55 B12.87 B13 B Total du passif 12.63 B12.61 B12.77 B12.65 B12.12 B12.09 B Total des capitaux propres 472 M542 M733 M906 M752 M903 M Total du passif et des capitaux propres 13.1 B13.16 B13.5 B13.55 B12.87 B13 B Dette totale 8.86 B8.94 B8.9 B8.83 B8.64 B8.57 B Dette nette 8.86 B8.94 B8.3 B8.16 B8.07 B7.45 B

Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

OGN

Financials

Organon & Co. Common Stock

Nouvelles

Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know

L’action Organon & Co atteint un sommet annuel à 13,44$

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

L’action Organon & Co atteint un plus haut sur 52 semaines à 13,4 USD

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It

An April To Remember For Stocks

Organon (OGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Organon (OGN) Q1 Earnings and Revenues Miss Estimates

Organon déçoit les attentes avec un chiffre d’affaires en baisse de 9%

Company News for Apr 28, 2026

Nasdaq Futures Slip as AI Concerns Resurface, FOMC Meeting and Earnings in Focus

Tech Earnings Optimism Powers Stocks Higher